Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
TERMINATED
NCT02900690
Health Economics Evaluation of the Management of Severe Postpartum Hemorrhage: Comparison of Recombinant Activated Factor VII Strategy to the Reference Strategy
Sponsor: Centre Hospitalier Universitaire de Nīmes
View on ClinicalTrials.gov
Summary
The main objective of this project is to assess the average cost of the treatment of bleeding postpartum with recombinant activated factor VII (NovoSeven®) and compare it to the reference strategy. Costs related to medicine NovoSeven® can generate surplus, but it also avoids in some cases very costly invasive procedures. It will be interesting to compare the average cost of the complete strategies supported.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
84
Start Date
2010-04-22
Completion Date
2010-11-05
Last Updated
2026-06-18
Healthy Volunteers
No
Conditions
Locations (1)
CHU de Nîmes
Nîmes, Gard, France